Using a drug facts box to communicate drug benefits and harms: two randomized trials.
about
Decision aids for people facing health treatment or screening decisionsDecision aids for people facing health treatment or screening decisionsPalliative medicine and decision science: the critical need for a shared agenda to foster informed patient choice in serious illnessScreening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic ReviewMedia, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medicationsThe impact of health literacy, patient-centered communication and shared decision-making on patients' satisfaction with care received in German primary care practicesWeb search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postingsWikiBuild: a new application to support patient and health care professional involvement in the development of patient support toolsDecision aids for people facing health treatment or screening decisionsPeople's Understanding of Verbal Risk Descriptors in Patient Information Leaflets: A Cross-Sectional National Survey of 18- to 65-Year-Olds in EnglandJudgment and decision making.Decision aids for patients.Lost in translation: helping patients understand the risks of inflammatory bowel disease therapy.Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers.The role of numeracy in moderating the influence of statistics in climate change messages.Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.Enhancing prescription drug innovation and adoptionPatient perceptions of osteoporosis treatment thresholdsComparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis.Developing and user-testing Decision boxes to facilitate shared decision making in primary care--a study protocol.Real life clinic visits do not match the ideals of shared decision makingMaking therapeutic decisions in inflammatory bowel disease: the role of patients.Extensions to regret-based decision curve analysis: an application to hospice referral for terminal patients.Presenting evidence-based health information for people with multiple sclerosis: the IN-DEEP project protocol.Advancing Best Practices for Prescription Drug Labeling.Designing concept maps for a precise and objective description of pharmaceutical innovations.Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.Could media reports include a standardized scale for quality of evidence?Beyond the black box: drug- and device-associated hypersensitivity eventsEffects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA testsDesign and evaluation of a software for the objective and easy-to-read presentation of new drug properties to physiciansSUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking.Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.Chances and risks in medical risk communication.Patients, health information, and guidelines: A focus-group studyThe Drug Facts Box: Improving the communication of prescription drug informationUse of tamoxifen and raloxifene for breast cancer chemoprevention in 2010Online health information seeking: how people with multiple sclerosis find, assess and integrate treatment information to manage their healthPrint advertisements for Alzheimer's disease drugs: informational and transformational features.Shared decision making in mental health: prospects for personalized medicine.
P2860
Q24200969-C60C9821-F4E8-48E3-B40C-5E72E18F6B2CQ24235817-05EDBBA8-DB45-4BF5-B41B-356BBB94E9D6Q24629373-CEE3FD21-3C49-49D7-89F5-C886C7A5D47BQ26748873-DA8F54A4-D3E3-41F3-A6BF-73F271F5E32BQ27013553-CC9EC105-0327-40AE-81BC-ADA4DB937A9AQ27305265-A2AACF67-4903-4F89-BEDD-3AA22A38ED61Q28656279-9F51A800-5590-4D93-8DF6-F7B04C554EB7Q28732129-D7E1CAC8-7F05-426D-BC16-C682E0D06220Q29994603-890B36AB-5188-4A03-BFFB-392435A4F418Q30148656-2DCA6AB8-CE64-42A6-B127-F680DF151072Q30377877-3BD2E3AD-33CA-406A-AB9F-F0151E919895Q30395096-FC93CD4D-C2D1-4499-AED6-96A0F1DF5D8CQ30498145-63CF9648-84A1-4EFB-AD30-46BDA9ED88DDQ30579901-BAC314F5-24AC-48F6-A6CC-AF6433CE15C7Q30653325-C94AFC92-823E-4333-994F-390222317A95Q33388078-9E0D469C-96B4-40B5-BD3C-985C6EFDF81AQ33725286-B4AB342F-AC4B-46EE-8C36-997F4971B858Q33766971-96B48B56-C9D6-42D8-B857-0BC526A61886Q33783212-6BA85AE2-2503-43DF-9134-6B484FF8C906Q33840383-DD2230B8-5E04-46A4-824A-7A2446C6F6D3Q33931784-C8D511A7-FB7A-484B-9B2C-77AF95593114Q33941262-2BA30A38-B430-41FB-80EA-5C38F314F6B8Q34111407-41DDA061-FB2A-4CAF-B2BA-EEE116B4FBD7Q34198335-6E741DB8-50D5-475E-8840-FC52506E3CC2Q34493395-235E89B4-CA46-42A7-BB9F-D7989B52FD04Q34554266-CCD40293-928E-4990-9503-A8E0C3BD1D7AQ34573294-CCC9086E-4EEF-4E0B-BD57-BB02ED3EEE5FQ34799138-1B5433AB-35B7-4C1B-8490-9EEB093BD374Q35026476-612D5AB9-9043-4EC0-B020-71F3AEAC0A1FQ35508095-1F9A5EB6-4CA5-428B-A154-D3FEA271C450Q35646560-BA76571F-12CD-4A39-88CF-D34EF7500287Q35734463-2EB32F3C-4DDF-470A-B433-6A83013E6F12Q35837043-4A830FA6-4397-4DC5-BEE1-9F5F63FE0AF7Q35865146-D9276E81-3772-4695-9D9D-B7C2F921D7FBQ36572038-7DD1B794-2B4B-4C2B-966C-9DF985B15165Q37117584-9511D486-09BF-4F05-AF20-3BBED9CBABEAQ37165630-304A5522-2FCA-4BAF-B26C-CDE242185618Q37321272-45121BCF-CEFE-46B1-8B3A-CDFB333C274AQ37659423-DAED583B-4411-4E24-B5C3-82CD4F616BA9Q37688001-55D42391-15C4-479B-8F70-9DABE7AB97EA
P2860
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@en
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@nl
type
label
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@en
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@nl
prefLabel
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@en
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@nl
P2093
P1476
Using a drug facts box to communicate drug benefits and harms: two randomized trials.
@en
P2093
H Gilbert Welch
Lisa M Schwartz
Steven Woloshin
P304
P356
10.7326/0003-4819-150-8-200904210-00106
P407
P577
2009-02-16T00:00:00Z